A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2013
11/12/2013	US8580273 TNF superfamily member light fusion proteins
11/12/2013	US8580269 Survivin peptides for autoimmune therapies
11/12/2013	US8580267 Immunocytokines for tumour therapy with chemotherapeutic agents
11/12/2013	US8580263 Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
11/12/2013	US8580253 Immunomodulating compositions and methods of use
11/12/2013	US8580252 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/12/2013	US8580251 PIM-3 kinase as a target for type 2 diabetes mellitus
11/12/2013	US8580246 Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor
11/12/2013	CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
11/12/2013	CA2664637C Dried reconstituted vesicle formation for pharmaceutical application
11/12/2013	CA2611924C Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
11/12/2013	CA2609811C Angiotensin i - converting enzyme (ace) inhibitors
11/12/2013	CA2607113C Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/12/2013	CA2587310C Tripeptide and tetrapeptide sulfones
11/12/2013	CA2586395C Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
11/12/2013	CA2576238C Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
11/12/2013	CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes
11/12/2013	CA2562729C Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1
11/12/2013	CA2548281C Method of preparation of mixed phase co-crystals with active agents
11/12/2013	CA2536643C Interferon-.beta. complex
11/12/2013	CA2522098C Absorption enhancers such as bht, bha or propylgallate
11/12/2013	CA2510823C Hemostatic compositions and devices
11/12/2013	CA2499458C Protein s protects the nervous system from injury
11/12/2013	CA2471924C Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
11/12/2013	CA2466701C Neuroprotective use of cyclic prolyl glycine
11/12/2013	CA2448379C Calorically dense liquid oral supplement
11/12/2013	CA2448022C Compositions for protein delivery via the pulmonary route
11/12/2013	CA2342376C A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/12/2013	CA2296071C Production and use of recombinant protein multimers with altered biological activity
11/08/2013	CA2793894A1 Cylodextrin complexation methods for formulating peptide proteasome inhibitors
11/07/2013	WO2013166502A1 Regulation of cardiac sodium channels by sirt1 and sirt1 activators
11/07/2013	WO2013166448A1 Stable formulations containing anti-pcsk9 antibodies
11/07/2013	WO2013166378A1 Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods
11/07/2013	WO2013166249A1 Dosing regimens for the treatment of pompe disease
11/07/2013	WO2013166218A1 Deactivation of urushiol and method of treatment and prevention of contact dermatitis
11/07/2013	WO2013166163A1 Compositions and methods for heparan sulfate as a biomarker for transplant rejection
11/07/2013	WO2013166043A1 Rejuvenation of precursor cells
11/07/2013	WO2013165554A1 Methods and compositions for modulating g-alpha-q signaling
11/07/2013	WO2013165304A1 Methods for modification of tissues
11/07/2013	WO2013165159A1 Composition for accelerating regeneration after laser surgery
11/07/2013	WO2013164822A1 Methods for extracting a tooth
11/07/2013	WO2013164484A1 Glucagon-like-peptide-2 (glp-2) analogues
11/07/2013	WO2013164483A1 Gip-glp-1 dual agonist compounds and methods
11/07/2013	WO2013164375A1 Pharmaceutical composition
11/07/2013	WO2013163766A1 ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A β-LACTAM ANTIBIOTIC
11/07/2013	WO2013163744A1 Nutrition formulation and product produced therefrom comprising whey protein.
11/07/2013	WO2013163689A1 Vaccine and uses thereof
11/07/2013	WO2013125730A3 Cationic graft-copolymer for drug delivery system
11/07/2013	WO2013123492A3 Glucose-responsive microgels for closed loop insulin delivery
11/07/2013	WO2013119170A3 Prevention of inflammatory disorders in domestic non-human mammals
11/07/2013	WO2013104909A4 Methods of preparing cells and compositions
11/07/2013	WO2012122378A3 Antibody-like proteins for therapeutic and diagnostic use
11/07/2013	WO2011156000A3 Use of il-4/il-13 antagonists to treat eosinophilic disorders
11/07/2013	WO2003033664A9 Bone anti-resorptive compounds
11/07/2013	WO2003023002A9 Novel human proteins, polynucleotides encoding them and methods of using the same
11/07/2013	WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
11/07/2013	US20130296533 Sebum Secretion-Blocking Composition, and Food or Beverage Containing Same
11/07/2013	US20130296260 Method for prevention or treatment of intractable inflammatory bowel disease
11/07/2013	US20130296259 Pharmaceutical compositions containing botulinum neurotoxin
11/07/2013	US20130296254 Compstatin and analogs thereof for eye disorders
11/07/2013	US20130296253 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum
11/07/2013	US20130296249 Methods of blocking tissue destruction by autoreactive t cells
11/07/2013	US20130296248 Methods of Treating Depression and Other Related Diseases
11/07/2013	US20130296243 Modified recombinant factor viii and von willebrand factor and methods of use
11/07/2013	US20130296239 Material for Wound Healing and Skin Reconstruction
11/07/2013	US20130296238 Method of treating amd in patients refractory to anti-vegf therapy
11/07/2013	US20130296236 Treatment protocol of diabetes type 2
11/07/2013	US20130296235 Container and method for storing a pharmaceutical agent
11/07/2013	US20130296233 Dietary Supplement and Methods of Use Thereof
11/07/2013	US20130296232 Peptides containing tryptophan
11/07/2013	US20130296228 Efflux pump inhibitors
11/07/2013	US20130296227 Antimicrobial cationic peptides and formulations thereof
11/07/2013	US20130296223 Use of thymosin alpha for the treatment of sepsis
11/07/2013	US20130296179 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/07/2013	US20130295604 Methods for producing modified glycoproteins
11/07/2013	US20130295589 Ngal for diagnosis of renal conditions
11/07/2013	US20130295202 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
11/07/2013	US20130295133 Recombinant virus expressing foreign dna encoding feline cd80, feline cd86, feline cd28, or feline ctla-4 and uses thereof
11/07/2013	US20130295130 Composition for promoting lipolysis
11/07/2013	US20130295122 Elastin digest compositions and methods utilizing same
11/07/2013	US20130295121 Covalent Diabodies and Uses Thereof
11/07/2013	US20130295096 Degraded agonist antibody
11/07/2013	US20130295093 Fusion constructs containing active sections of tnf ligands
11/07/2013	US20130295092 Method for the Treatment of Neurodegenerative Diseases
11/07/2013	US20130295082 Antibody formulations and methods
11/07/2013	US20130295078 Method of improving absorption of vitamin e by a pet animal
11/07/2013	US20130295076 Mcpip as wound therapy
11/07/2013	US20130295075 Compositions and methods of treating glaucoma
11/07/2013	US20130295073 Use of pegylated recombinant human arginase for treatment of leukemia
11/07/2013	US20130295071 Methods and compositions for cns delivery of b-galactocerebrosidase
11/07/2013	US20130295068 Combination preparation for improving sperm quality
11/07/2013	US20130295062 Methods and compositions for treatment of alzheimer's disease
11/07/2013	US20130295047 Clip modulation for the treatment of mucosal diseases
11/07/2013	US20130295046 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
11/07/2013	US20130295045 Medicament comprising recombinant antibody against chemokine receptor ccr4
11/07/2013	US20130295042 Peptides and Peptide Mimetics to Treat Pathologies Associated With Eye Disease
11/07/2013	US20130295012 Shear controlled release for stenotic lesions and thrombolytic therapies
11/07/2013	US20130295011 Bacterial nitroreductase enzymes and methods relating thereto
11/07/2013	US20130295005 Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
11/07/2013	CA2839781A1 Nutrition formulation and product produced therefrom

1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 3163